Evidence map›Paper›PMID 33435475›Full record

Trial reportNutrients2021

The Effect of Gum Arabic (Acacia Senegal) on Cardiovascular Risk Factors and Gastrointestinal Symptoms in Adults at Risk of Metabolic Syndrome: A Randomized Clinical Trial.

Amjad H Jarrar, Lily Stojanovska, Vasso Apostolopoulos, Jack Feehan, Mo'ath F Bataineh, Leila Cheikh Ismail, Ayesha S Al Dhaheri

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06836206 (The Effect of Gum Arabic), which is not on this map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06836206 phase1 / phase2recruitingnot on this mapstarted 2025, after this paper: background citation

The Effect of Gum Arabic (GA) on Adult Dialysis Patients in Abu Dhabi: A Prospective Randomized-controlled Trial (The GADAD Study)

TypeinterventionalSponsorAbu Dhabi Health Services CompanyRan2025 to 2026Enrolled40ConditionsEnd Stage Renal Disease (ESRD)ArmsGum Arabic, Water
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Therapeutic Potential of Gum Arabic (Journal of clinical medicine · 2024
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Amjad H JarrarNutrition and Health Department, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain 15551, UAE.
Lily StojanovskaNutrition and Health Department, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain 15551, UAE.
Vasso ApostolopoulosInstitute for Health and Sport, Victoria University, Melbourne 3011, Australia.ORCID 0000-0001-6788-2771
Jack FeehanInstitute for Health and Sport, Victoria University, Melbourne 3011, Australia.ORCID 0000-0002-9627-1299
Mo'ath F BatainehDepartment of Sport and Rehabilitation, The Hashemite University, 13115 Zarqa, Jordan.
Leila Cheikh IsmailClinical Nutrition and Dietetics Department, College of Health Sciences, University of Sharjah, Sharjah 27272, UAE.
Ayesha S Al DhaheriNutrition and Health Department, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain 15551, UAE.ORCID 0000-0002-7634-3531
United Arab Emirates University · AEHashemite University · JOThe University of Melbourne · AUUniversity of Sharjah · AEVictoria University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gum Arabic (GA) is a widely-used additive in food processing, but is also historically used in a number of traditional therapies. It has been shown to have a broad range of health benefits, particularly in improving important cardiovascular risk indicators. Metabolic syndrome and its associated cardiac outcomes are a significant burden on modern healthcare systems, and complementary interventions to aid in its management are required. We aimed to examine the effect of GA on those with, or at risk of, metabolic syndrome to identify an effect on improving important disease parameters related to cardiovascular outcomes. A single-blind, randomized, placebo-controlled trial was conducted to identify the effects of daily GA supplementation on metabolic and cardiovascular risk factors. A total of 80 participants were randomized to receive 20 g of GA daily (

Indexed as

AcaciaAdolescentAdultBlood PressureCardiovascular DiseasesDietary FiberFemaleGastrointestinal DiseasesGlycated HemoglobinGum ArabicHeart Disease Risk FactorsHumansMaleMetabolic SyndromeMiddle AgedSingle-Blind MethodDietary FiberGlycated HemoglobinGum Arabichemoglobin A1c protein, humanAcacia SenegalAcacia SeyalGum ArabicMetabolic Syndrome

Identifiers

PMID33435475
PMCPMC7826716
OpenAlexW3120545150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.